Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Journal of Electrocardiology
- Vol. 37, 15-24
- https://doi.org/10.1016/j.jelectrocard.2004.08.004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Assessing predictors of drug-induced torsade de pointesTrends in Pharmacological Sciences, 2003
- Electrophysiological Mechanism of Enhanced Susceptibility of Hypertrophied Heart to Acquired Torsade de Pointes ArrhythmiasCirculation, 2002
- Influence of transmural repolarization gradients on the electrophysiology and pharmacology of ventricular myocardium. Cellular basis for the Brugada and long–QT syndromesPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2001
- The M Cell:Journal of Cardiovascular Electrophysiology, 1999
- Modification of inactivation in cardiac sodium channels: ionic current studies with Anthopleurin-A toxin.The Journal of general physiology, 1995
- Role of intracellular sodium in the regulation of intracellular calcium and contractility. Effects of DPI 201-106 on excitation-contraction coupling in human ventricular myocardium.Journal of Clinical Investigation, 1988
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patientsJournal of the American College of Cardiology, 1983
- Quinidine SyncopeCirculation, 1964